Compare Abeona Therapeutics Inc (ABEO) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while T-Rex 2X Long MSTR Daily Target ETF trades at $1.87. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | MSTU | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $7.23 | $106.80 |
52-Week Low | $4.17 | $1.46 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
MSTU trades at $2.15, unchanged on the day, with a bearish technical outlook indicated by moving averages and ADX signals. The ETF has experienced extreme volatility, with news reports highlighting a 95% annual decline. Key support and resistance are at $2 and $3, respectively. Financial ratios are unavailable, and the fund's performance is directly tied to the daily moves of its underlying asset.
The outlook for MSTU is highly speculative and carries significant risk due to its leveraged structure, which can amplify losses. Investor sentiment is negative following substantial historical declines. Any investment is a high-risk bet on short-term price movements of the underlying asset, not a long-term fundamental holding.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →
